This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Vaidya JS et al. (1996) Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer 74: 820–824
Bartelink H et al. (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345: 1378–1387
Massarut S et al. (2006) Intraoperative radiotherapy impairs breast cancer cell motility induced by surgical wound fluid. J Clin Oncol 24 (Suppl 18): 10611
Vaidya JS et al. (2001) Targeted Intraoperative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol 12: 1075–1080
Kraus-Tiefenbacher U et al. (2006) Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery. Int J Radiat Oncol Biol Phys 66: 377–381
Joseph DJ et al. (2004) Prospective trial of intraoperative radiation treatment for breast cancer. Aust NZ J Surg 74: 1043–1048
Kraus-Tiefenbacher U et al. (2006) Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer—acute toxicity. Onkologie 29: 77–82
Vaidya JS et al. (2006) Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost. Int J Rad Oncol Biol Phys 66: 1335–1338
Vaidya JS et al. (1999) Targeted Intraoperative Radiotherapy (TARGIT)—trial protocol. [http://www.thelancet.com/journals/lancet/misc/protocol/99PRT-47] (accessed 2 May 2007)
Enderling H et al. (2007) A mathematical model of breast cancer development, local treatment and recurrence. J Theor Biol 246: 245–259
Author information
Authors and Affiliations
Ethics declarations
Competing interests
Dr Vaidya has been reimbursed for travel expenses to international steering committee meetings by Carl Zeiss, the manufacturer of Intrabeam. However both the Targit-A and Targit-B trials are academically driven and so was the manufacture of the original radiotherapy device.
Rights and permissions
About this article
Cite this article
Vaidya, J. Partial breast irradiation using targeted intraoperative radiotherapy (Targit). Nat Rev Clin Oncol 4, 384–385 (2007). https://doi.org/10.1038/ncponc0850
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0850
This article is cited by
-
Radiobiological Comparison of Hypofractionated Accelerated Partial-Breast Irradiation (APBI) and Single-Dose Intraoperative Radiotherapy (IORT) with 50-kV X-Rays
Strahlentherapie und Onkologie (2010)
-
Xoft Axxent® electronic brachytherapy—a new device for delivering brachytherapy to the breast
Nature Reviews Clinical Oncology (2009)
-
Current management of DCIS: a review
Breast Cancer Research and Treatment (2008)